Raymond James Downgrades Adamis Pharmaceuticals (ADMP) to Market Perform
Tweet
Share
E-mailGet Alerts ADMP Hot Sheet
Price: $0.78 --0%
Rating Summary:
3 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 8 | New: 6
Rating Summary:
3 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 8 | New: 6
Join SI Premium – FREE
Raymond James analyst Elliot Wilbur downgraded Adamis Pharmaceuticals (NASDAQ: ADMP) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Adamis Pharmaceuticals click here. For more ratings news on Adamis Pharmaceuticals click here.
Shares of Adamis Pharmaceuticals closed at $1.26 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Abercrombie & Fitch (ANF) to Market Perform
- Deutsche Bank Downgrades Oxford Biomedica (OXB:LN) (OXBDF) to Hold
- UBS Downgrades Planisware SA (PLNW:FP) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
